XML 32 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows
$ in Thousands
 12 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net income $ 545,034 $ 483,168 $ 530,228
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 314,406 294,077 230,203
Impairment of equity method investments 41,057 70,895 0
Impairment of net assets held for sale and goodwill 47,102 33,244 0
Stock-based compensation expense 27,695 22,760 22,832
Deferred income taxes 7,109 (2,180) (46,537)
Other (16,311) 8,466 8,683
Changes in operating assets and liabilities, net of effects from acquisitions and dispositions:      
Receivables, net 26,419 241 (55,979)
Inventories 15,460 (127,153) (203,857)
Prepaid income taxes/income taxes payable 25,776 (2,125) 8,376
Accounts payable 3,712 (77,621) 45,136
Other operating assets and liabilities 26,574 6,967 (20,185)
Net cash provided by operating activities 1,064,033 710,739 518,900
Purchases of property, plant and equipment (265,730) (250,027) (179,090)
Proceeds from Disposal of Property, Plant, and Equipment 16,045 27,659 8,707
Acquisitions, net of cash and restricted cash acquired (27,296) (1,214,995) (513,088)
Proceeds from disposal of businesses 18,469 0 301,297
Investments in unconsolidated subsidiaries (7,594) (60,300) (7,664)
Receipts of deferred purchase price on receivables under factoring arrangements 0 36,991 0
Other investing activities, net 1,253 1,733 5,243
Net cash used in investing activities (264,853) (1,458,939) (384,595)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Debt issuance costs 0 (21,128) (4,267)
Proceeds from issuance of Euro Notes (2026/28) 0 1,232,100 0
Purchase of treasury stock (291,813) (60,000) 0
Borrowings under revolving credit facilities 605,708 1,667,325 839,171
Repayments under revolving credit facilities (734,471) (1,528,970) (946,477)
Repayments under term loans (8,750) (354,800) (27,884)
Borrowings under receivables securitization facility 36,600 10,120 11,245
Repayments under receivables securitization facility (146,600) (120) (11,245)
Payment of notes issued and assumed debt from acquisitions (19,123) (54,888) 0
(Repayments) borrowings of other debt, net (33,922) (11,730) 19,706
Other financing activities, net 8,298 (5,086) (7,184)
Net cash (used in) provided by financing activities (600,669) 882,995 (112,567)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (904) (77,311) 23,512
Net increase in cash, cash equivalents and restricted cash 197,607 57,484 45,250
Cash, cash equivalents and restricted cash of continuing operations, beginning of period 337,250 279,766 227,400
Add: Cash, cash equivalents and restricted cash of discontinued operations, beginning of period 0 0 (7,116)
Cash, cash equivalents and restricted cash of continuing and discontinued operations, beginning of period 337,250 279,766 234,516
Less: Cash and cash equivalents of discontinued operations, end of period 6,470 0 0
Cash, cash equivalents and restricted cash of continuing and discontinued operations, end of period 534,857 337,250 279,766
Reconciliation Of Cash, Cash Equivalents And Restricted Cash [Abstract]      
Cash and cash equivalents 523,020 331,761 279,766
Restricted cash included in Other noncurrent assets 5,367 5,489 0
Cash, cash equivalents and restricted cash, end of period 528,387 337,250 279,766
Supplemental disclosure of cash paid for:      
Income taxes, net of refunds 181,306 200,098 273,019
Interest 143,121 137,866 95,707
Supplemental disclosure of noncash investing and financing activities:      
Stock issued in acquisitions 0 251,334 0
Noncash property, plant and equipment additions 10,154 16,518 18,122
Notes payable and other financing obligations, including notes issued, debt assumed and settlement of pre-existing balances in connection with business acquisitions 47,887 105,566 59,045
Notes and other financing receivables in connection with disposals of business/investment 0 0 4,000
Notes issued in connection with purchase of noncontrolling interest 14,196 0 0
Contingent consideration liabilities $ 6,627 $ 3,107 $ 6,234